A breakthrough advancement in tissue oxygenation imaging


We are excited to introduce SnapshotNIR, the newest advancement in tissue oxygenation imaging. The low cost and easy to use imaging device is completely non-invasive, eliminating the need for contact or the injected dyes required by other technologies. Instantly capture diagnostic insight into the availability of oxygenated blood in tissue. Providing improved decision making throughout the dynamic treatment pathway – before, during and after wound or surgical care.

Clinical Results


Browse the many scientifically peer reviewed articles and case studies on Kent’s multispectral imaging device. Clinical research and the validation of Kent’s technology are key to understanding the importance of the SnapshotNIR throughout the healthcare industry.

“Kent has always been at the forefront of innovation. We rapidly evolve our technology, processes and people to continuously improve the solutions we deliver. We strive to develop solutions that impress, motivate and deliver.  Improving patient outcomes is our mission.”

Pierre Lemire, CEO


Introducing SnapshotNIR

  • Instant Tissue Oxygen Saturation Values
  • Non-Invasive, No Injectable Dyes
  • Ease-of-Use with Minimum Training
  • Low Cost & No Disposables
  • Lightweight Handheld Device
  • Accurate, Unlimited Imaging
  • Touch Screen with 8+ hr Battery


Multi-Use Imaging Solution

  • Limb Preservation
  • Chronic Wound
  • Amputation Assesment
  • Reconstructive Surgery


Revolutionary Multispectral Imaging

  • FDA Cleared Device
  • Licensed by Health Canada
  • ISO 13485 Certification
  • Proprietary & Patented Technology
  • Near Inferred (NIR) Imaging
  • StO2 Oxygenation Values